Morishita Jintan Co., Ltd. (TYO:4524)

Market Cap	8.53B
Revenue (ttm)	12.64B
Net Income (ttm)	312.00M
Shares Out	4.09M
EPS (ttm)	76.33
PE Ratio	27.33
Forward PE	n/a
Dividend	55.00 (2.63%)
Ex-Dividend Date	Mar 28, 2025

Volume	2,200
Average Volume	3,475
Open	2,090.00
Previous Close	2,086.00
Day's Range	2,075.00 - 2,090.00
52-Week Range	1,950.00 - 2,520.00
Beta	-0.10
RSI	46.01
Earnings Date	May 13, 2025

About Morishita Jintan

Morishita Jintan Co., Ltd. produces and distributes pharmaceuticals, quasi drugs, medical devices, and food products in Japan. It operates through Healthcare Business and Capsule Business divisions. The Healthcare Business division manufactures and sells Jintan branded products, as well as engages in OEM of dietary supplements, cosmetics, foods, etc. The Capsule Business division is involved in the OEM/ODM of pharmaceuticals, foods, etc., as well as the development of industrial use capsules. Morishita Jintan Co., Ltd. was founded in 1893 and i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 354
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4524

Financial Performance

In 2023, Morishita Jintan's revenue was 12.41 billion, an increase of 9.22% compared to the previous year's 11.36 billion. Earnings were 697.00 million, an increase of 41.96%.